TY - JOUR T1 - Repeat warning on ▾ valproate in pregnancy as message fails to raise awareness JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 75 LP - 75 DO - 10.1136/dtb.2017.7.0497 VL - 55 IS - 7 A2 - , Y1 - 2017/07/01 UR - http://dtb.bmj.com/content/55/7/75.1.abstract N2 - Repeat warning on ▾ valproate in pregnancy as message fails to raise awarenessThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued the latest in a series of alerts on the risks of developmental disorders and birth defects associated with use of valproate-containing medicines during pregnancy.1 In 2015, the MHRA highlighted data that showed that babies born to mothers who take medicines related to valproate during pregnancy have a 30-40% risk of developmental disability and a 10% risk of birth defects.2 Despite communications to prescribers in January 2015 and February 2016 on the … ER -